A postmenopause-like model of ovariectomized Wistar rats to identify active principles of Erythrina lysistemon (Fabaceae)

Fitoterapia

Volumn 82, Issue 7, 2011, Pages 939-949

  Mvondo, M A ^a   Njamen, D ^a   Fomum, S Tanee ^a   Wandji, J ^a   Vollmer, Günter ^b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Antiatherogenic; Estrogenicity; Flavanone; Hot flushes; Isoflavone; Postmenopause

Indexed keywords

ABYSSINONE V 4' METHYL ETHER 4H 1 BENZOPYRAN 4 ONE 2,3 DIHYDRO 5,7 DIHYDROXY 2 [4 METHOXY 3,5 BIS(3 METHYL 2 BUTEN 1 YL)PHENYL]; ALPINUMISOFLAVONE 5 HYDROXY 7 (4 HYDROXYPHENYL) 2 2 DIMETHYL 2H 6H BENZO [1,2-B: 5,4 B]DIPYRAN 6 ONE; CHOLESTEROL; ERYTHRINA LYSISTEMON EXTRACT; ESTRADIOL VALERATE; ESTROGEN RECEPTOR; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE RECEPTOR STIMULATING AGENT; ISOFLAVONE; LUTEINIZING HORMONE; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BODY WEIGHT; CARBON NUCLEAR MAGNETIC RESONANCE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHRINA LYSISTEMON; ESTROGEN ACTIVITY; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADECTOMY; HISTOLOGY; IN VIVO STUDY; LIGAND BINDING; LUTEINIZING HORMONE BLOOD LEVEL; MEDICINAL PLANT; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RECEPTOR BINDING; TREATMENT DURATION; ULTRAVIOLET SPECTROSCOPY; UTERINE EPITHELIAL HEIGHT; UTERUS; UTERUS WEIGHT; VAGINA; VAGINAL EPITHELIAL HEIGHT; WEIGHT, MASS AND SIZE; WISTAR RAT;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, HDL; ERYTHRINA; ESTRADIOL; ESTROGENS; FEMALE; MODELS, ANIMAL; OVARIECTOMY; PHYTOTHERAPY; PLANT EXTRACTS; POSTMENOPAUSE; RATS; RATS, WISTAR; REFERENCE VALUES; UTERUS; VAGINA;

ERYTHRINA (ANGIOSPERM); ERYTHRINA LYSISTEMON; FABACEAE; RATTUS; RATTUS NORVEGICUS;

EID: 80052167826     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2011.05.009     Document Type: Article

References (75)

1. P. Diel, S. Schmidt, and G. Vollmer In vivo test systems for the quantitative and qualitative analysis of the biological activity of phytoestrogens J Chromatogr B Analyt Technol Biomed Life Sci 777 1-2 2002 191 202 (Pubitemid 35257872)
2. J.V. Pinkerton, D.W. Stovall, and R.S. Kighlinger Advances in the treatment of menopausal symptoms Womens Health 5 2009 361 384
3. M.R. McClung The menopause and HRT. Prevention and management of osteoporosis Best Pract Res Clin Endocrinol Metab 17 2003 53 71
4. R.T. Turner, B.L. Riggs, and T.C. Spelsberg Skeletal effects of estrogen Endocr Rev 15 1994 275 300 (Pubitemid 24180788)
5. X.P. Yang, and J.F. Reckelhoff Estrogen, hormonal replacement therapy and cardiovascular disease Curr Opin Nephrol Hypertens 20 2011 133 138
6. T.S. Mikkola, and T.B. Clarkson Estrogen replacement therapy, atherosclerosis, and vascular function Cardiovasc Res 53 2002 605
7. P.S. Derry Hormones, menopause, and heart disease: making sense of the Women's Health Initiative Womens Health Issues 14 2004 212 219 (Pubitemid 39602747)
8. V. Beral Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427 (Pubitemid 36999703)
9. P. Kaufert, P. Boggs, B. Ettinger, N.F. Woods, W.H. Utian, Women and menopause: beliefs, attitudes and behaviors. The North American Menopause Society 1997 Menopause Survey, Menopause. 5 (1998) 197-202. (Pubitemid 28562721)
10. A. Ferrari Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms J Obstet Gynaecol Res 35 2009 1083 1090
11. D.M. Eisenberg, R.B. Davis, S.L. Ettner, S. Appel, S. Wilkey, and M. Van Rompay Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey J Am Med Assoc 280 1998 1569 1575 (Pubitemid 28520643)
12. W. Wuttke, H. Jarry, and D. Seidlová-Wuttke Isoflavones-safe food additives or dangerous drugs? Ageing Research Rev 6 2007 150 188 (Pubitemid 47017808)
13. F.A. Bisby, J. Buckingham, J.B. Harborne, Phytochemical Dictionary of the Leguminosae, Vol. 1, Plants and their Constituents, Chapman & Hall, London, 1994.
14. P.M. Dewick, Isoflavonoids, in: J.B. Harborne, (Eds.), The Flavonoids. Advances in Research since 1986, Chapman & Hall, London, 1994, pp. 117-238.
15. S. El-Masry, M.E. Amer, M.S. Abdel-Kader, and H.H. Zaatout Prenylated flavonoids of Erythrina lysistemon grown in Egypt Phytochemistry 60 2002 783 787
16. D. Njamen, E. Talla, J.T. Mbafor, Z.T. Fomum, A. Kamanyi, J.C. Mbanya, M. Cerdá-Nicolas, R.M. Giner, M.C. Recio, and J.L. Rios Anti-inflammatory activity of erycristagallin, a pterocarpene from Erythrina mildbraedi Eur J Pharmacol 468 2003 67 74 (Pubitemid 36555753)
17. A.E. Nkengfack, A.G.B. Azebaze, A.K. Waffo, Z.T. Fomum, M. Meyer, and F.R. van Heerden Erythrina studies. Part 39. Cytotoxic isoflavones from Erythrina indica Phytochemistry 58 2001 1113 1120 (Pubitemid 33130974)
18. C.C.N. Pillay, A.K. Jäger, D.A. Mulholland, and J.V. Staden Cylooxygenase inhibiting and anti-bacterial activities of South African Erythrina species J Ethnopharmacol 74 2001 2001 231 237 (Pubitemid 32215452)
19. M.E. Amer, S. El-Masry, M. Shamma, and A.J. Freyer Three novel glycodienoid alkaloids from Erythrina lysistemon J Nat Prod 54 1991 161 166
20. B.F. Juma, and R.R.T. Majinda Erythinaline alkaloids from the flowers and pods of Erythrina lysistemon and their DPPH radical scavenging properties Phytochemistry 65 2004 13 1404
21. T.T. Dao, P.H. Nguyen, P.T. Thuong, K.W. Kang, M. Na, D.T. Ndinteh, J.T. Mbafor, and W.K. Oh Pterocarpans with inhibitory effects on protein tyrosine phosphatase 1B from Erythrina lysistemon Hutch Phytochemistry 70 2009 2053 2057
22. F.S.F. Tanee, D. Njamen, C.B. Magne ndé, J. Wandji, O. Zierau, Z.T. Fomum, and G. Vollmer Estrogenic effects of the ethylacetate extract of the stem bark of Erythrina lysistemon Hutch (Fabaceae) Phytomedicine 14 2007 222 226 (Pubitemid 46136940)
23. M. Dobiášová, and J. Frohlich The plasma parameter log (Tg/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)) Clin Biochem 34 2001 583 588 (Pubitemid 34014853)
24. K.I. Ohno, T. Fukushima, N. Waizumi, H. Tokuyama, M. Maeda, and K. Imai Estrogen receptor binding assay method for endocrine disruptors using fluorescence polarization Anal Chem 74 2002 3491 3496
25. B.M. Abegaz, T.B. Ngadjui, E. Dongo, and H. Tamboue Prenylated chalcones and flavones from the leaves of Dorstenia kameruniana Phytochemistry 49 1998 1147 1150 (Pubitemid 28457656)
26. R. Borges-Argaez, L.M. Peña-Rodriguez, and P.G. Waterman Cytotoxic and antiprotozal activity of flavonoids from Lonchocarpus spp Phytochemistry 60 2002 533
27. B.T. Ngadjui, B. Ngameni, E. Dongo, S.F. Kouam, and B.M. Abegaz Prenylated and geranylated chalcones and flavones from the aerial parts of Dorstenia ciliata Bull Chem Soc Ethiop 16 2002 157 163 (Pubitemid 36160340)
28. H. Keh-Feng, and H. Chin-Jong Constituents of the stem bark of Erythrina arborescens J Chin Med 12 2001 61 67
29. A. Yenesew, J.O. Midiwo, and P.G. Waterman Rotinoids, isoflavones and chalcones from the stem bark of Millettia usaramensis subspecies usarmensis Phytochemistry 47 1998 951 955
30. P.R. Casson, K.E. Elkind-Hirsch, J.E. Buster, P.J. Homsby, S.A. Carson, and M.C. Snubes Effects of postmenopausal estrogen replacement on circulating androgens Obstet Gynecol 90 6 1997 995 998 (Pubitemid 27510144)
31. C.D. Gardner, L.M. Chatterjee, and A.A. Franke Effects of isoflavone supplements vs. soy food on blood concentrations of genistein and daidzein in adults J Nutr Biochem 20 2009 227 234
32. F.R. Westwood The female rat reproductive cycle: a practical histological guide to staging Toxicol Pathol 36 2008 375 384
33. D.L. Buchanan, T. Kurita, J.A. Taylor, D.B. Lubahn, G.R. Cunha, and P.S. Cooke Role of stromal and epithelial estrogen receptors in vaginal epithelial proliferation, stratification, and cornification Endocrinology 139 1998 4345 4352 (Pubitemid 28513724)
34. D.L. Buchanan, T. Setiawan, D.B. Lubahn, J.A. Taylor, T. Kurita, G.R. Cunha, and P.S. Cooke Tissue compartment-specific estrogen receptor-a participation in the mouse uterine epithelial secretory response Endocrinology 140 1999 484 491 (Pubitemid 29011195)
35. J.F. Couse, S.W. Curtis, T.F. Washburn, J. Lindzey, T.S. Golding, D.B. Lubahn, O. Smithies, and K.S. Korach Analysis of transcription and estrogen insensitivity in the female mouse after target disruption of the estrogen receptor gene Mol Endocrinol 9 1995 1441 1454
36. D.F. Archer Neoplasia of the female reproductive tract: effects of hormone therapy Endocrine 24 2004 259 263 (Pubitemid 41271159)
37. D. Seidlova-Wuttke, T. Becker, V. Christoffel, H. Jarry, and W. Wuttke Silymarin is a selective estrogen receptor beta (ERbeta) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats J Steroid Biochem Mol Biol 86 2003 179 188 (Pubitemid 37243995)
38. S.C. Hewitt, B.J. Deroo, K. Hansen, J. Collins, S. Grissom, C.A. Afshari, and K.S. Korach Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen Mol Endocrinol 17 2003 2070 2083 (Pubitemid 37281798)
39. Z. Weihua, S. Andersson, G. Cheng, E.R. Simpson, M. Warner, and J.A. Gustafsson Update on estrogen signalling FEBS Lett 546 2003 17 24
40. V. Unfer, M.L. Casini, L. Costabile, M. Mignosa, S. Gerli, and G.C. Di Renzo Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study Fertil Steril 82 2004 145 148 (quiz 265) (Pubitemid 38968790)
41. Z. Weihua, S. Saji, S. Mäkinen, G. Cheng, E.V. Jensen, M. Warner, and J.A. Gustafsson Estrogen receptor (ER) β, a modulator of ERα in the uterus Proc Natl Acad Sci USA 97 2000 5936 5941
42. A. Naaz, M. Zakroczymski, P. Heine, J. Taylor, P. Saunders, D. Lubahn, and P.S. Cooke Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha.): a potential role for estrogen receptor beta (ERβ) Horm Metab Res 34 2002 758 763 (Pubitemid 36398720)
43. C. Belanger, V. Luu-The, P. Dupont, and A. Tchernof Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity Horm Metab Res 34 2002 737 745 (Pubitemid 36398717)
44. C. Ohlsson, N. Hellberg, P. Parini, O. Vidal, M. Bohlooly, M. Rudling, M.K. Lindberg, M. Warner, B. Angelin, and J.A. Gustafsson Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice Biochem Biophys Res Commun 278 2000 640 645
45. P.A. Heine, J.A. Taylor, G.A. Iwamoto, D.B. Lubahn, and P.S. Cooke Increased adipose tissue in male and female estrogen receptor-alpha knockout mice Proc Natl Acad Sci USA 97 2000 12729 12734
46. M. Cosma, J. Bailey, J.M. Miles, C.Y. Bowers, and J.D. Veldhuis Pituitary and/or peripheral estrogen-receptor α regulates follicle-stimulating hormone secretion, whereas central estrogenic pathways direct growth hormone and prolactin secretion in postmenopausal women J Clin Endocrinol Metab 93 2008 951 958 (Pubitemid 351398579)
47. C. Gohlke-Barwolf Coronary artery disease: is menopause a risk factor? Basic Res Cardiol 95 2000 I77 I83
48. L. Baker, K.K. Meldrum, M. Wang, R. Sankula, R. Vanam, A. Raiesdana, B. Tsai, K. Hile, J.W. Brown, and D.R. Meldrum The role of estrogen in cardiovascular disease J Surg Res 115 2003 325 344 (Pubitemid 38021925)
49. B.W. Walsh, I. Schiff, B. Rosner, L. Greenberg, V. Ravnikar, and F.M. Sacks Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins N Engl J Med 325 1991 1196 1204
50. Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial JAMA 273 1995 199 208
51. M. Böttner, J. Christoffel, and W. Wuttke Effects of long-term treatment with 8-prenylnaringenin and oral estradiol on the GH-IGF-1 axis and lipid metabolism in rats J Endocrinol 198 2008 395 401
52. B. Staels, H. Jansen, A. van Tol, G. Stahnke, H. Will, G. Verhoeven, and J. Auwerx Development, food intake, and ethinylestradiol influence hepatic triglyceride lipase and LDL-receptor mRNA levels in rats J Lipid Res 31 1990 1211 1218 (Pubitemid 20224718)
53. D. Applebaum-Bowden, P. McLean, A. Steinmetz, D. Fontana, C. Matthys, G.R. Warnick, M. Cheung, J.J. Albers, and W.R. Hazzard Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women J Lipid Res 30 1989 1895 1906 (Pubitemid 20030368)
54. R.S. Kushwaha, D.M. Foster, V.N. Murthy, K.D. Carey, and M.G. Bernard Metabolic regulation of apoproteins of high-density lipoproteins by estrogen and progesterone in the baboon (Papio sp) Metabolism 39 1990 544 552 (Pubitemid 20156323)
55. K. Moorthy, U.C. Yadav, A.K. Mantha, S.M. Cowsik, D. Sharma, S.F. Basir, and N.Z. Baquer Estradiol and progesterone treatments change the lipid profile in naturally menopausal rats from different age groups Biogerontology 5 2004 411 419 (Pubitemid 40057984)
56. L. Di Croce, G. Bruscalupi, and A. Trentalance Independent behavior of rat liver LDL receptor and HMGCoA reductase under estrogen treatment Biochem Biophys Res Commun 224 1996 345 350 (Pubitemid 26268191)
57. P. Parini, B. Angelin, A. Stavreus-Evers, B. Freyschuss, H. Eriksson, and M. Rudling Biphasic effects of the natural estrogen 17b-estradiol on hepatic cholesterol metabolism in intact female rats Arterioscler Thromb Vasc Biol 20 2000 1817 1823 (Pubitemid 30470600)
58. M. Böttner, and W. Wuttke Chronic treatment with physiological doses of estradiol affects the GH-IGF-1 axis and fat metabolism in young and middle-aged ovariectomized rats Biogerontology 7 2006 91 100 (Pubitemid 43950779)
59. H. Klammer, C. Schlecht, W. Wuttke, and H. Jarry Multi-organic risk assessment of estrogenic properties of octyl-methoxycinnamate in vivo A 5-day sub-acute pharmacodynamic study with ovariectomized rats Toxicology 215 2005 90 96 (Pubitemid 41423655)
60. K.E. Friday, C. Dong, and R.U. Fontenot Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes J Clin Endocrinol Metab 86 2001 48 52 (Pubitemid 32109774)
61. T. Fait, J. Malkova, and J. Zivny Effect of hormone replacement therapy on the cardiovascular system Cesk' Gynekologie 67 2002 285 293 (Pubitemid 35175875)
62. K. Saglam, Z. Polat, M.I. Yilmaz, M. Gulec, and S.B. Akinci Effects of postmenopausal hormone replacement therapy on insulin resistance Endocrine 18 2002 211 214 (Pubitemid 35239782)
63. M. Dobiášová, J. Frohlich, M. šedová, M.C. Cheung, B.G. Brown, Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography, J. Lipid Res. (2011). Available at: http://WWW.jlr.org/content/early/2011/01/11/ jlr.P011668full.pdf. Accessed on 31 January 2011.
64. M. Dobiášová, J. Stříbrná, P.H. Pritchard, and J.J. Frohlich Cholesterol esterification rate in plasma depleted of very low and low density lipoproteins is controlled by the proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men J Lipid Res 33 1992 1411 1418
65. C.J. Fielding, and P.E. Fielding Molecular physiology of reverse cholesterol transport J Lipid Res 36 1995 211 228
66. A. Rigotti, B. Trigatti, J. Babitt, M. Fenman, S. Xu, and M. Krieger Scavenger receptor BI-a cell surface receptor for high density lipoprotein Curr Opin Lipidol 8 1997 181 188 (Pubitemid 27290465)
67. B.L. Lasley, C.F. Wang, and S.S. Yen The effects of estrogen and progesterone on the functional capacity of the gonadotrophs J Clin Endocrinol Metab 41 1975 820 826
68. C.F. Wang, B.L. Lasley, A. Lein, and S.C. Yen The functional changes of the pituitary gonadotrophs during the menstrual cycle J Clin Endocrinol Metab 42 1976 718 728
69. I.E. Messinis, S. Milingos, K. Zikopoulos, G. Hasiotis, K. Seferiadis, and D. Lolis Luteinizing hormone response to gonadotrophin releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone Hum Reprod 13 1998 2415 2420 (Pubitemid 28451216)
70. H.G. Burger The endocrinology of the menopause Maturitas 23 1996 129 136 (Pubitemid 126351815)
71. A.D. Genazzani, F. Petraglia, L. Sgarbi, V. Montanini, B. Hartmann, N. Surico, A. Biolcati, A. Volpe, and A.R. Genazzani Difference of LH and FSH secretory characteristics and degree of concordance between postmenopausal and aging women Maturitas 26 1997 133 138 (Pubitemid 27138203)
72. M.A. Shupnik Gonadotropin gene modulation by steroids and gonadotropin-releasing hormone Biol Reprod 54 1996 279 286 (Pubitemid 26031395)
73. R.F. Casper, S.S.C. Yen, and M.M. Wilkes Menopausal flushes: a neuroendocrine link with pulsatile luteinizing hormone secretion Science 205 1979 823 825 (Pubitemid 10245928)
74. J. Böttner, H. Christoffel, and W. Jarry Wuttke, effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on pituitary function in rats J Endocrinol 189 2006 77 88
75. D. Seidlova-Wuttke, O. Hesse, H. Jarry, V. Christoffel, B. Spengler, T. Becker, and W. Wuttke Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17 beta Eur J Endocrinol 149 2003 351 362 (Pubitemid 37304707)